## MELI: MercadoLibre, Inc. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.97 indicates fundamental undervaluation. Quality metrics strong (ROE 41%).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($1854.05)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 6
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Moody’s Rating Upgrades MercadoLibre, Inc. (MELI), Here’s Why**
- Source: Insider Monkey | 20251221T094500 | Bullish | Relevance: 100%
- Moody's Ratings has upgraded MercadoLibre, Inc. (MELI) to investment grade with a Baa3 issuer rating and a stable outlook, citing improved debt levels, cash flow, profitability, and fintech transparency. This upgrade signifies a lower-risk investment. Additionally, MercadoLibre announced a strategic agreement with Agility Robotics to integrate Digit humanoid robots into its fulfillment facilities to enhance productivity and worker safety.

**2. Flputnam Investment Management Co. Grows Stock Position in MercadoLibre, Inc. $MELI**
- Source: MarketBeat | 20251221T120928 | Neutral | Relevance: 100%
- Flputnam Investment Management Co. significantly increased its stake in MercadoLibre, Inc. (NASDAQ:MELI) by 1,395.1% in the third quarter, now holding 7,012 shares valued at $16.39 million. This move is part of a broader trend of institutional investors growing their positions, while company insiders have recently sold shares. MercadoLibre reported mixed Q3 results with revenue beating estimates but EPS missing, and the stock currently holds a "Moderate Buy" rating from analysts.

**3. MercadoLibre, Inc. $MELI Position Trimmed by Zevenbergen Capital Investments LLC**
- Source: MarketBeat | 20251220T140925 | Somewhat-Bullish | Relevance: 100%
- Zevenbergen Capital Investments LLC reduced its stake in MercadoLibre, Inc. (NASDAQ:MELI) by 4.6% in the third quarter, selling 5,163 shares and now holding 106,242 shares valued at approximately $248.28 million. This reduction makes MercadoLibre the 6th largest position in Zevenbergen's portfolio, representing 4.8% of their total holdings. Despite missing EPS estimates, MercadoLibre saw a significant revenue increase, and analysts maintain a "Moderate Buy" rating with an average price target of $2,842.94.

**4. MercadoLibre, Inc. $MELI is Perpetual Ltd's 9th Largest Position**
- Source: MarketBeat | 20251220T130925 | Neutral | Relevance: 100%
- Perpetual Ltd reduced its stake in MercadoLibre, Inc. by 15.3% in Q3, making it their 9th largest holding. Despite missing Q3 EPS estimates, MercadoLibre saw a 39.5% year-over-year revenue increase, and analysts maintain a "Moderate Buy" consensus with an average target price of $2,842.94. Institutional ownership remains high at 87.62%, though insiders have sold shares totaling approximately $2.31 million in the last three months.

**5. 556 Shares in MercadoLibre, Inc. $MELI Acquired by Lifestyle Asset Management Inc.**
- Source: MarketBeat | 20251220T120925 | Somewhat-Bullish | Relevance: 100%
- Lifestyle Asset Management Inc. acquired 556 shares of MercadoLibre, Inc. (NASDAQ:MELI) valued at approximately $1.3 million during the third quarter, increasing institutional ownership to 87.62%. Despite MercadoLibre missing its Q3 EPS estimate, its revenue surpassed expectations, growing by 39.5% year-over-year. Analysts maintain a "Moderate Buy" rating for MELI with a consensus price target of $2,842.94.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | Wedbush | $2700 | $2800 | -4% |
| 2025-12-04 | BTIG | $2750 | $2750 | 0% |
| 2025-11-24 | UBS | $2900 | $3000 | -3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | Wedbush | main | Outperform |
| 2025-12-04 | BTIG | reit | Buy |
| 2025-11-24 | UBS | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 3 ($2.31M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 38.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- JPMORGAN CHASE & CO: 7.0% (+78.3%)
- BAILLIE GIFFORD & CO: 6.5% (-5.4%)
- Morgan Stanley: 3.9% (+0.3%)
- Capital Research Glo: 3.6% (+3.4%)
- Capital World Invest: 3.4% (+1.3%)

### Key Risks

1. Long-term trend broken: trading 12.1% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.97 indicates undervaluation relative to growth. Forward P/E 33.4x attractive for 49% earnings growth. Quality metrics strong (ROE 41%). Balance sheet: $2.5B free cash flow. Revenue growth strong at 29% YoY. Analyst sentiment negative (2 target cuts vs 0 raises). Insider selling cluster ($2.3M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $101.1B |
| Beta | 1.43 |
| 52W Range | $1693.01 - $2645.22 |
| Short Interest | 1.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.97 |
| Forward P/E | 33.4 |
| Current P/E | 49.7 |
| YoY Growth | 49.2% |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from -5.0% to -2.4% (+2.6% in 5 days), confirming momentum buildup. Below STRENGTH zone by 6.4pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.3%) - potential reversal signal. Underperforming sector by 4.2pp, stock-specific weakness. Below SMA200 (0.88x), long-term trend not supportive. MACD histogram bearish (-0.86), momentum weakening. RSI neutral at 45. OFD pattern: -SLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.39% (CS: 23) | Weak |
| RSI_14 | 45.0 | Neutral |
| MACD Histogram | -0.86 | Bearish |
| vs SMA20 | 0.982x | Below |
| vs SMA50 | 0.951x | Below |
| vs SMA200 | 0.879x | Below |

### Decision

- **Verdict:** HOLD
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $1993.65
- **Stop Loss:** $1854.05 (7.0% risk)
- **Target:** $2272.85 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 6
- **Position Value:** $11,961.90
- **Portfolio %:** 11.96%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-24 (Est: $11.71)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $9.30 | $8.32 | -10.5% |
| 2025Q2 | $11.89 | $10.31 | -13.3% |
| 2025Q1 | $8.27 | $9.74 | +17.8% |
| 2024Q4 | $7.56 | $12.61 | +66.8% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*